FRANKLIN, Tenn. / Apr 12, 2023 / Business Wire / Community Health Systems, Inc. (NYSE:CYH) today announced that it will webcast its first quarter 2023 conference call.
The Company will issue a press release announcing its results on Monday, May 1, 2023, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central time, 11:00 a.m. Eastern time, on Tuesday, May 2, 2023. A live webcast of the conference call will be available online at www.chs.net. The online replay will follow shortly after the call and continue for approximately 30 days.
During this call, Community Health Systems will review the Company’s financial and operating results for the first quarter ended March 31, 2023.
About Community Health Systems, Inc.
Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company's affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 44 distinct markets across 15 states. CHS subsidiaries own or lease 78 affiliated hospitals with approximately 13,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. More information about the Company can be found on its website at www.chs.net.
Last Trade: | US$3.33 |
Daily Change: | -0.08 -2.35 |
Daily Volume: | 1,174,087 |
Market Cap: | US$467.230M |
February 18, 2025 December 11, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load